Identifying and Killing Myeloma Cells That Cause Myeloma and Relapse with MCRI Award Winner Dr. Frank Zhan and Dr. Yogesh Jethava

Identifying and Killing Myeloma Cells That Cause Myeloma and Relapse with MCRI Award Winner Dr. Frank Zhan and Dr. Yogesh Jethava
Event Description
Fenghauang (Frank) Zhan, PhD
Yogesh Jethava, MD
University of Iowa
Interview Date: December 11, 2018
What cells cause myeloma and why do patients relapse after treatment? Myeloma stem cells may be part of the answer.
Fenghauang (Frank) Zhan, PhD was recently selected as a Myeloma Crowd Research Initiative (MCRI) award recipient. The goal of the MCRI is to help optimize myeloma therapy for individual patients.
Dr. Zhan's noticed that patients whose myeloma is resistant to chemotherapy have higher levels of CD24 on their flow cytometry tests. He believes that the CD24 is present on the myeloma "stem cells" - cells that initiate the cancer and cause relapse. His work will validate that CD24 can indicate patients who are more prone to have resistant disease and is working with other researchers who are developing CD24-directed treatments.
If patients were able to receive full myeloma therapy including therapy that could kill initiating cells, we would be much closer to a cure. Hear more in this show from Dr. Zhan and Dr. Jethava from the University of Iowa about this important research.
The Myeloma Crowd created the MCRI because we “Can’t Wait for a Cure.” Through the MCRI we want to help find the right treatment for the right patient at the right time. The MCRI is funding three research projects – each with a different focus – that will also integrate with HealthTree, a new tool for myeloma patients. Learn more about HealthTree here.
Thanks to our episode sponsor
Schedule & Agenda
Speakers & Moderators

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org






Get the Latest Multiple Myeloma Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.